Evidence map›Paper›PMID 9159154›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1997

Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase.

W Y Chen, E C Bailey, S L McCune, J Y Dong, T M Townes

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. ER exit in physiology and disease.Frontiers in molecular biosciences · 2024
    Review
  9. The Mechanism of Leptin Resistance in Obesity and Therapeutic Perspective.Advances in experimental medicine and biology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

W Y ChenDepartment of Biochemistry and Molecular Genetics, Schools of Medicine and Dentistry, University of Alabama, Birmingham, AL 35294, USA.
E C Bailey
S L McCune
J Y Dong
T M Townes

Funding

HUMAN GLOBIN GENE EXPRESSION DURING DEVELOPMENTR01HL035559 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI TOWNES, TIM M. · 1986 to 2002
$871k
COLLABORATIVE PROJECTS ON MINORITY HEALTH--PROJECT IR01HL051649 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI TOWNES, TIM M. · 1994 to 1997
–
NHLBI NIH HHS HL 35559NHLBI NIH HHS HL51649
6 · The paper itself

Abstract

Retroviral and adeno-associated viral sequences can dramatically silence transgene expression in mice. We now report that this repression also occurs in stably infected HeLa cells when the cells are grown without selection. Expression of a transduced lacZ gene (rAAV/CMVlacZ) is silenced in greater than 90% of cells after 60 days in culture. Surprisingly, high-level expression can be reactivated by treating the cells with sodium butyrate or trichostatin A but not with 5-azacytidine. When cell clones with integrated copies of rAAV/CMVlacZ were isolated, lacZ expression was silenced in 80% of the clones; however, lacZ expression was reactivated in all of the silenced clones by treatment with butyrate or trichostatin A. The two drugs also reactivated a silenced globin gene construct (rAAV/HS2alphabetaAS3) in stably infected K562 cells. Trichostatin A is a specific inhibitor of histone deacetylase; therefore, we propose that hyperacetylation of histones after drug treatment changes the structure of chromatin on integrated viral sequences and relieves repression of transduced genes. The reactivation of silenced, transduced genes has implications for gene therapy. Efficient viral gene transfer followed by drug treatment to relieve suppression may provide a powerful combination for treatment of various genetic and infectious diseases.

Indexed as

Histone Deacetylase InhibitorsAnimalsAzacitidinebeta-GalactosidaseButyratesButyric AcidCloning, MolecularCytomegalovirusDependovirusEnzyme InhibitorsGene ExpressionGenes, ReporterGenetic TherapyGenetic VectorsGlobinsHeLa CellsAzacitidinebeta-GalactosidaseButyratesButyric AcidEnzyme InhibitorsGlobinsHistone Deacetylase InhibitorsHydroxamic AcidsRecombinant Proteinstrichostatin A

Identifiers

PMID9159154
PMCPMC20860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.